UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000013937
Receipt No. R000016248
Scientific Title Moduration of anticancer effect by 4-methylumbelliferone
Date of disclosure of the study information 2014/06/01
Last modified on 2014/05/12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Moduration of anticancer effect by 4-methylumbelliferone
Acronym Moduration of anticancer effect by 4-methylumbelliferone
Scientific Title Moduration of anticancer effect by 4-methylumbelliferone
Scientific Title:Acronym Moduration of anticancer effect by 4-methylumbelliferone
Region
Japan

Condition
Condition gastrointestinal and hepato-biliary-pancreatic cancer
Classification by specialty
Gastrointestinal surgery Hepato-biliary-pancreatic surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 analysis of the efficacy of 4-methylumbelliferone as an anticancer agent
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes inhibition of the grouth rate of cultured cancer tissue
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria gastrointestinal and hepato-biliary-pancreatic cancer
Key exclusion criteria non
Target sample size 300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Daisuke Kudo
Organization Hirosaki University, Graduate School of Medicine
Division name Department of the Gastroenterological Surgery
Zip code
Address 5 zaifu-cho, Hirosaki
TEL 0172-39-5079
Email aikopapa@cc.hirosaki-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Daisuke Kudo
Organization Hirosaki University, Graduate School of Medicine
Division name Department of the Gastroenterological Surgery
Zip code
Address 5 zaifu-cho, Hirosaki
TEL 0172-39-5079
Homepage URL
Email aikopapa@cc.hirosaki-u.ac.jp

Sponsor
Institute Hirosaki University, Graduate School of Medicine
Institute
Department

Funding Source
Organization Hirosaki University, Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 06 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2013 Year 03 Month 31 Day
Date of IRB
Anticipated trial start date
2013 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information anticancer effect of 4-methylumbelliferone

Management information
Registered date
2014 Year 05 Month 12 Day
Last modified on
2014 Year 05 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016248

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.